• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-8 通过 STAT3/AKT/NF-κB 通路促进前列腺癌细胞的增殖和抑制凋亡。

IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer.

机构信息

Department of Clinical Laboratory, Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine, Nanjing 210000, P.R. China.

Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210000, P.R. China.

出版信息

Mol Med Rep. 2017 Dec;16(6):9035-9042. doi: 10.3892/mmr.2017.7747. Epub 2017 Oct 10.

DOI:10.3892/mmr.2017.7747
PMID:29039490
Abstract

Interleukin-8 (IL-8) possesses tumorigenic and proangiogenic properties, and is overexpressed in many human cancer types. However, only few studies have demonstrated the mechanisms of action of IL‑8 regarding the ability to promote proliferation and to inhibit apoptosis in prostate cancer. Here, the aim of the present study was to investigate the effects of IL‑8 on the prostate cancer cell line and determine possible mechanisms underlying its effect. In this study, IL‑8 was shown to be significantly upregulated in prostate cancer compared with paired normal control tissues. The data showed that IL‑8 exhibits direct oncogenicity, which significantly induced cell proliferation, invasion and attenuated apoptosis in prostate cancer cells via signal transducer and activator of transcription 3/protein kinase B/nuclear factor‑κB signaling pathways. In conclusion, modulation of IL‑8 expression or its associated signaling pathway may provide a novel working mechanism of IL‑8 in prostate cancer, and a promising strategy for controlling the progression and metastasis of prostate cancer.

摘要

白细胞介素-8(IL-8)具有致瘤和促血管生成特性,在许多人类癌症类型中过度表达。然而,只有少数研究表明了 IL-8 促进前列腺癌细胞增殖和抑制细胞凋亡的作用机制。本研究旨在探讨 IL-8 对前列腺癌细胞系的影响,并确定其作用的可能机制。本研究表明,与配对的正常对照组织相比,前列腺癌中 IL-8 的表达显著上调。研究数据表明,IL-8 具有直接致癌性,通过信号转导和转录激活因子 3/蛋白激酶 B/核因子-κB 信号通路显著诱导前列腺癌细胞增殖、侵袭和减弱细胞凋亡。总之,调节 IL-8 的表达或其相关信号通路可能为 IL-8 在前列腺癌中的作用提供新的工作机制,并为控制前列腺癌的进展和转移提供有前途的策略。

相似文献

1
IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer.白细胞介素-8 通过 STAT3/AKT/NF-κB 通路促进前列腺癌细胞的增殖和抑制凋亡。
Mol Med Rep. 2017 Dec;16(6):9035-9042. doi: 10.3892/mmr.2017.7747. Epub 2017 Oct 10.
2
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.从Nexrutine中提取的含有小檗碱或相关化合物的丁醇馏分可抑制NFκB信号传导并诱导前列腺癌细胞凋亡。
Prostate. 2009 Apr 1;69(5):494-504. doi: 10.1002/pros.20899.
3
c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt.c-Jun氨基末端激酶通过信号转导和转录激活因子3及Akt介导瘦素刺激的雄激素非依赖性前列腺癌细胞增殖。
Biochim Biophys Acta. 2008 Oct;1782(10):593-604. doi: 10.1016/j.bbadis.2008.07.005. Epub 2008 Aug 5.
4
Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.霉菌毒素疣孢菌素A通过抑制促生存的Akt/NF-κB/mTOR信号传导来抑制前列腺癌细胞的增殖并诱导其凋亡。
J Exp Ther Oncol. 2016 Nov;11(4):251-260.
5
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.溶血磷脂酸通过Akt/IκBα信号通路激活RhoA和NF-κB,并通过增强功能性侵袭伪足的形成促进前列腺癌的侵袭和进展。
Tumour Biol. 2016 May;37(5):6775-85. doi: 10.1007/s13277-015-4549-x. Epub 2015 Dec 10.
6
EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.EC-70124,一种新型糖基化吲哚咔唑多激酶抑制剂,通过抑制信号转导和转录激活因子3(STAT3)和核因子κB(NF-κB)逆转前列腺癌的致瘤性和干细胞特性。
Mol Cancer Ther. 2016 May;15(5):806-18. doi: 10.1158/1535-7163.MCT-15-0791. Epub 2016 Jan 29.
7
PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.PEDF 通过 PEDF 受体/磷脂酶 A2 抑制前列腺癌细胞中 IL8 的产生,并调节 NFκB 和 PPARγ。
Cytokine. 2011 Aug;55(2):202-10. doi: 10.1016/j.cyto.2011.04.010. Epub 2011 May 13.
8
Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.白杨素(5,7-二羟基-4'-甲氧基黄酮)通过抑制前列腺癌细胞中的 NF-κB/Akt 信号通路表现出体外和体内的抗癌活性。
Int J Mol Med. 2014 Feb;33(2):317-24. doi: 10.3892/ijmm.2013.1571. Epub 2013 Nov 27.
9
Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.3,3'-二吲哚甲烷对雄激素受体的下调作用有助于抑制激素敏感的LNCaP和不敏感的C4-2B前列腺癌细胞的增殖并诱导其凋亡。
Cancer Res. 2006 Oct 15;66(20):10064-72. doi: 10.1158/0008-5472.CAN-06-2011.
10
Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells.羟基酪醇诱导前列腺癌细胞凋亡和细胞周期停滞并抑制多种致癌信号通路。
Nutr Cancer. 2017 Aug-Sep;69(6):932-942. doi: 10.1080/01635581.2017.1339818. Epub 2017 Jul 18.

引用本文的文献

1
The immune landscape of systemic inflammation in prostate cancer.前列腺癌全身炎症的免疫格局。
Cancer Biol Med. 2025 Sep 4;22(8). doi: 10.20892/j.issn.2095-3941.2025.0149.
2
Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer.靶向细胞因子和趋化因子信号通路以增强结直肠癌的化疗敏感性
Cell Commun Signal. 2025 Aug 12;23(1):369. doi: 10.1186/s12964-025-02235-7.
3
The heat of the battle: inflammation's role in prostate cancer development and inflammation-targeted therapies.
战斗的热度:炎症在前列腺癌发展中的作用及针对炎症的治疗方法
Discov Oncol. 2025 Feb 1;16(1):108. doi: 10.1007/s12672-025-01829-4.
4
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.基质重塑与前列腺癌预后之间联系的证据。
Cancers (Basel). 2024 Sep 21;16(18):3215. doi: 10.3390/cancers16183215.
5
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance.靶向前列腺癌中的白细胞介素-8及其受体:炎症、应激反应与治疗抵抗
Cancers (Basel). 2024 Aug 8;16(16):2797. doi: 10.3390/cancers16162797.
6
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.促炎细胞因子和 CXC 趋化因子(CXCL1-CXCL16)在前列腺癌进展中的作用:对其治疗管理的深入了解。
Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9.
7
Mapping the core senescence phenotype of primary human colon fibroblasts.绘制原代人结肠成纤维细胞的衰老核心表型图谱。
Aging (Albany NY). 2024 Feb 21;16(4):3068-3087. doi: 10.18632/aging.205577.
8
Inhibition of protein kinase C isozymes causes immune profile alteration and possibly decreased tumorigenesis in bladder cancer.抑制蛋白激酶C同工酶会导致免疫特征改变,并可能降低膀胱癌的肿瘤发生。
Am J Cancer Res. 2023 Aug 15;13(8):3832-3852. eCollection 2023.
9
CXCL8 and the peritoneal metastasis of ovarian and gastric cancer.CXCL8 与卵巢癌和胃癌的腹膜转移。
Front Immunol. 2023 Jun 12;14:1159061. doi: 10.3389/fimmu.2023.1159061. eCollection 2023.
10
Osteoid cell-derived chemokines drive bone-metastatic prostate cancer.类骨质细胞衍生的趋化因子驱动骨转移性前列腺癌。
Front Oncol. 2023 Mar 21;13:1100585. doi: 10.3389/fonc.2023.1100585. eCollection 2023.